Refractory hypotension with end-organ hypoperfusion is an ominous feat
ure of inflammatory shock. In the past fifteen years, nitric oxide (a
diffusible, short-lived product of arginine metabolism) has been found
to be an important regulatory molecule in several areas of metabolism
, including vascular tone control. Vascular endothelial cells constitu
tively produce low levels of nitric oxide that regulate blood pressure
by mediating adjacent smooth-muscle relaxation. In an inflammatory sh
ock state, cytokines, like interleukin-1 and tumor necrosis factor-alp
ha, induce a separate, high-output form of the enzyme that synthesizes
nitric oxide in both endothelial and smooth-muscle cells. The ensuing
high rates of nitric oxide formation result in extensive smooth-muscl
e relaxation, presser refractory vasodilation, and-ultimately-shock. T
he concept of the pathogenesis of inflammatory shock explains many lim
itations of current therapies and may foster the development of new in
terventions to mitigate the effects of nitric oxide overproduction in
this syndrome.